ASPET is the premier scientific organization for pharmacologists. Since 1908, ASPET has been committed to providing our members with the tools and resources to advance their careers, promote their research and discipline, and build lasting relationships with fellow colleagues.
Over the last 100 years, ASPET has grown to over 5,000 members. Our membership includes researchers and students in academia, industry, and government from all over the world. We are extremely proud to be associated with some of the world’s most prominent scientists, including 16 Nobel Laureates, who have made major contributions to pharmacology. ASPET members continue to make a major impact in health and medicine, receiving high honors and appointments throughout their career.
ASPET membership is open to anyone with a genuine interest in pharmacology and experimental therapeutics. We invite you to explore the benefits of membership and join our prestigious group of scientists today!
ASPET offers special rates of interest to members in developing countries. Please see the dues page for more information.
ASPET provides many opportunities for members to get involved and make an impact on the Society and the greater pharmacology community. Explore ASPET’s divisions, committees, and chapters to learn about and engage in your scientific community.
ASPET has ten different divisions to facilitate interaction among
members with similar research interests. ASPET members are required to
choose to affiliate with one primary division and as many secondary
divisions as they like.
Committees are established by the ASPET bylaws to oversee various aspects of the organization.
ASPET has three regional chapters that provide opportunities, particularly for students, to meet at regional venues to discuss their research. Poster competitions for students and postdoctoral fellows are a feature of the regional chapter meetings.
The regional chapters are distinct entities from ASPET and members of a regional chapter are not necessarily members of ASPET.
Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics